Advertisement

Prognostication

  • Brian Mac Grory
  • David Y. HwangEmail author
Chapter

Abstract

A patient’s prognosis refers to the expected course of his or her disease process, including not only timing of eventual death but also future functional status and quality of life while living, with or without treatment. Understanding prognosis is central to establishing patient-centered goals and making decisions about disease-directed treatment as well as hospice, and represents one of the main elements of discussion when talking about serious news and establishing goals of care. Formulating an accurate prognosis for the neurologic patient presents a challenge for clinicians, who must weigh both subjective impressions and any available objective outcome data carefully. Communicating an estimated prognosis to a patient and his or her family—including talking about the prognostic uncertainty inherent in neurologic diseases—presents its own potential pitfalls. This chapter (1) outlines the central importance of prognosis in neurology, (2) highlights challenges that neurologists face in determining prognosis, and (3) discusses communication of prognostic estimates with neurologic patients and their families.

Keywords

Prognosis Palliative care Neurology End-of-life care Communication Surrogate decision-making Shared decision-making Self-fulfilling prophecy Prognostic uncertainty Prognostic discordance 

References

  1. 1.
    Jackson VA, Jacobsen J, Greer JA, Pirl WF, Temel JS, Back AL. The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide. J Palliat Med. 2013;16(8):894–900.PubMedCrossRefGoogle Scholar
  2. 2.
    Ahalt C, Walter LC, Yourman L, Eng C, Pérez-Stable EJ, Smith AK. “Knowing is better”: preferences of diverse older adults for discussing prognosis. J Gen Intern Med. 2012;27(5):568–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ. 2004;328(7452):1343.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Russell BJ, Ward AM. Deciding what information is necessary: do patients with advanced cancer want to know all the details? Cancer Manag Res. 2011;3:191–9.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Nyborn JA, Olcese M, Nickerson T, Mack JW. “Don’t try to cover the sky with your hands”: parents’ experiences with prognosis communication about their children with advanced cancer. J Palliat Med. 2016;19(6):626–31.PubMedCrossRefGoogle Scholar
  6. 6.
    Becker KJ, Baxter AB, Cohen WA, Bybee HM, Tirschwell DL, Newell DW, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68(20):1651–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Morgenstern LB, Zahuranec DB, Sánchez BN, Becker KJ, Geraghty M, Hughes R, et al. Full medical support for intracerebral hemorrhage. Neurology. 2015;84(17):1739–44.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR. Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg. 1996;85(1):39–49.PubMedCrossRefGoogle Scholar
  10. 10.
    Kelly AG, Hoskins KD, Holloway RG. Early stroke mortality, patient preferences, and the withdrawal of care bias. Neurology. 2012;79(9):941–4.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Izzy S, Compton R, Carandang R, Hall W, Muehlschlegel S. Self-fulfilling prophecies through withdrawal of care: do they exist in traumatic brain injury, too? Neurocrit Care. 2013;19(3):347–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Sarkar P, Cole A, Scolding NJ, Rice CM. Percutaneous endoscopic gastrostomy tube insertion in neurodegenerative disease: a retrospective study and literature review. Clin Endosc. 2017;50(3):270–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Gené Badia J, Borràs Santos A, Contel Segura JC, Terén CA, González LC, Ramírez EL, et al. Predictors of mortality among elderly dependent home care patients. BMC Health Serv Res. 2013;13:316.PubMedCrossRefGoogle Scholar
  14. 14.
    Holloway RG, Gramling R, Kelly AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013;80(8):764–72.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, et al. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(6):1887–916.PubMedCrossRefGoogle Scholar
  16. 16.
    Bernat JL. Observations on ethical issues in the neuro-ICU. Neurocrit Care. 2015;23(1):1–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.PubMedCrossRefGoogle Scholar
  18. 18.
    Rabinstein AA, Hemphill JC. Prognosticating after severe acute brain disease: science, art, and biases. Neurology. 2010;74(14):1086–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182–92.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2(2):110–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Martínez-Martín P, Rojo-Abuin JM, Rodríguez-Violante M, Serrano-Dueñas M, Garretto N, Martínez-Castrillo JC, Arillo VC, Fernández W, Chaná-Cuevas P, Arakaki T, Alvarez M, Ibañez IP, Rodríguez-Blázquez C, Chaudhuri KR, Merello M. Analysis of four scales for global severity evaluation in Parkinson’s disease. NPJ Parkinsons Dis. 2016;2:16007.  https://doi.org/10.1038/npjparkd.2016.7. eCollection 2016.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Benejam B, Sahuquillo J, Poca MA, Frascheri L, Solana E, Delgado P, et al. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol. 2009;256(7):1126–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Weil AG, Rahme R, Moumdjian R, Bouthillier A, Bojanowski MW. Quality of life following hemicraniectomy for malignant MCA territory infarction. Can J Neurol Sci. 2011;38(3):434–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Velseboer DC, de Bie RM, Wieske L, Evans JR, Mason SL, Foltynie T, et al. Development and external validation of a prognostic model in newly diagnosed Parkinson disease. Neurology. 2016;86(11):986–93.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12(1):5–11.PubMedGoogle Scholar
  26. 26.
    Linklater G, Lawton S, Fielding S, Macaulay L, Carroll D, Pang D. Introducing the Palliative Performance Scale to clinicians: the Grampian experience. BMJ Support Palliat Care. 2012;2(2):121–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Hwang DY, Dell CA, Sparks MJ, Watson TD, Langefeld CD, Comeau ME, et al. Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes. Neurology. 2016;86(2):126–33.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Korolev IO, Symonds LL, Bozoki AC, Initiative ADN. Predicting progression from mild cognitive impairment to Alzheimer’s dementia using clinical, MRI, and plasma biomarkers via probabilistic pattern classification. PLoS One. 2016;11(2):e0138866.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Bozoki AC, An H, Bozoki ES, Little RJ. The existence of cognitive plateaus in Alzheimer’s disease. Alzheimers Dement. 2009;5(6):470–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Galea I, Lederer C, Neuhaus A, Muraro PA, Scalfari A, Koch-Henriksen N, et al. A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. Eur J Neurol. 2013;20(7):1107–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Moroni M, Zocchi D, Bolognesi D, Abernethy A, Rondelli R, Savorani G, et al. The ‘surprise’ question in advanced cancer patients: a prospective study among general practitioners. Palliat Med. 2014;28(7):959–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Moss AH, Ganjoo J, Sharma S, Gansor J, Senft S, Weaner B, et al. Utility of the “surprise” question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol. 2008;3(5):1379–84.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, et al. Prognostic significance of the “surprise” question in cancer patients. J Palliat Med. 2010;13(7):837–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.PubMedCrossRefGoogle Scholar
  35. 35.
    Thai JN, Walter LC, Eng C, Smith AK. Every patient is an individual: clinicians balance individual factors when discussing prognosis with diverse frail elderly adults. J Am Geriatr Soc. 2013;61(2):264–9.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386–96.PubMedCrossRefGoogle Scholar
  37. 37.
    Schonberg MA, Smith AK. Discussing long-term prognosis in primary care: hard but necessary. JAMA Intern Med. 2016;176(5):678–80.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Smith AK, Williams BA, Lo B. Discussing overall prognosis with the very elderly. N Engl J Med. 2011;365(23):2149–51.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Seymour JE, French J, Richardson E. Dying matters: let’s talk about it. BMJ. 2010;341:c4860.PubMedCrossRefGoogle Scholar
  40. 40.
    Chapman AR, Litton E, Chamberlain J, Ho KM. The effect of prognostic data presentation format on perceived risk among surrogate decision makers of critically ill patients: a randomized comparative trial. J Crit Care. 2015;30(2):231–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Slovic P, Finucane ML, Peters E, MacGregor DG. Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal. 2004;24(2):311–22.PubMedCrossRefGoogle Scholar
  42. 42.
    Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011;103(19):1436–43.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Ubel PA, Smith DM, Zikmund-Fisher BJ, Derry HA, McClure J, Stark A, et al. Testing whether decision aids introduce cognitive biases: results of a randomized trial. Patient Educ Couns. 2010;80(2):158–63.PubMedCrossRefGoogle Scholar
  44. 44.
    Smith AK, White DB, Arnold RM. Uncertainty – the other side of prognosis. N Engl J Med. 2013;368(26):2448–50.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Evans LR, Boyd EA, Malvar G, Apatira L, Luce JM, Lo B, et al. Surrogate decision-makers’ perspectives on discussing prognosis in the face of uncertainty. Am J Respir Crit Care Med. 2009;179(1):48–53.PubMedCrossRefGoogle Scholar
  46. 46.
    Apatira L, Boyd EA, Malvar G, Evans LR, Luce JM, Lo B, et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Ann Intern Med. 2008;149(12):861–8.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Back AL, Arnold RM, Quill TE. Hope for the best, and prepare for the worst. Ann Intern Med. 2003;138(5):439–43.PubMedCrossRefGoogle Scholar
  48. 48.
    Kimbell B, Murray SA, Macpherson S, Boyd K. Embracing inherent uncertainty in advanced illness. BMJ. 2016;354:i3802.PubMedCrossRefGoogle Scholar
  49. 49.
    Saposnik G, Redelmeier D, Ruff CC, Tobler PN. Cognitive biases associated with medical decisions: a systematic review. BMC Med Inform Decis Mak. 2016;16(1):138.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011;306(13):1483–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Chiarchiaro J, Buddadhumaruk P, Arnold RM, White DB. Quality of communication in the ICU and surrogate’s understanding of prognosis. Crit Care Med. 2015;43(3):542–8.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    White DB, Ernecoff N, Buddadhumaruk P, Hong S, Weissfeld L, Curtis JR, et al. Prevalence of and factors related to discordance about prognosis between physicians and surrogate decision makers of critically ill patients. JAMA. 2016;315(19):2086–94.PubMedCrossRefGoogle Scholar
  53. 53.
    Chahine LM, Malik B, Davis M. Palliative care needs of patients with neurologic or neurosurgical conditions. Eur J Neurol. 2008;15(12):1265–72.PubMedCrossRefGoogle Scholar
  54. 54.
    Tran LN, Back AL, Creutzfeldt CJ. Palliative care consultations in the neuro-ICU: a qualitative study. Neurocrit Care. 2016;25(2):266–72.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Turner-Stokes L, Sykes N, Silber E, Khatri A, Sutton L, Young E. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions. Clin Med (Lond). 2007;7(2):129–36.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurologyYale University School of MedicineNew HavenUSA
  2. 2.Division of Neurocritical Care and Emergency NeurologyYale School of MedicineNew HavenUSA

Personalised recommendations